PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹367 Cr | ₹369 Cr | ₹656 Cr | ₹368 Cr | ₹407 Cr |
What is the latest Contingent Liabilities ratio of PANACEA BIOTEC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹369 Cr |
| Mar2023 | ₹656 Cr |
| Mar2022 | ₹368 Cr |
| Mar2021 | ₹407 Cr |
How is Contingent Liabilities of PANACEA BIOTEC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | -0.62 | |
| Mar2024 | ₹369 Cr | -43.67 | |
| Mar2023 | ₹656 Cr | 78.11 | |
| Mar2022 | ₹368 Cr | -9.54 | |
| Mar2021 | ₹407 Cr | - | |
Compare Contingent Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,301.2 Cr | 2.3% | -6.3% | -16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | -0.1% | -2.4% | 13.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.7% | 12.9% | 54.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 1.8% | 2.5% | 40.9% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 0.6% | -3.8% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 3.3% | 1.3% | -7.6% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 2.3% |
-6.3% |
-16.6% |
| SENSEX | 0.7% |
-3.5% |
-9.2% |
You may also like the below Video Courses